{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:01:30Z","timestamp":1793404890714,"version":"4.5.0"},"reference-count":115,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CNS Drugs"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s40263-026-01310-y","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T05:26:58Z","timestamp":1782710818000},"page":"1037-1049","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Emerging Pharmacological Strategies for Trigeminal Neuralgia"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5345-141X","authenticated-orcid":false,"given":"Juliana Geremias","family":"Chichorro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1715-7146","authenticated-orcid":false,"given":"Victor Augusto Benedicto","family":"dos Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0644-9066","authenticated-orcid":false,"given":"Gerald W.","family":"Zamponi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"issue":"9","key":"1310_CR1","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/s1474-4422(20)30233-7","volume":"19","author":"L Bendtsen","year":"2020","unstructured":"Bendtsen L, et al. Advances in diagnosis, classification, pathophysiology, and management of trigeminal neuralgia (in eng). Lancet Neurol. 2020;19(9):784\u201396. https:\/\/doi.org\/10.1016\/s1474-4422(20)30233-7.","journal-title":"Lancet Neurol"},{"issue":"6","key":"1310_CR2","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1097\/j.pain.0000000000000853","volume":"158","author":"JM Zakrzewska","year":"2017","unstructured":"Zakrzewska JM, Wu J, Mon-Williams M, Phillips N, Pavitt SH. Evaluating the impact of trigeminal neuralgia (in eng). Pain. 2017;158(6):1166\u201374. https:\/\/doi.org\/10.1097\/j.pain.0000000000000853.","journal-title":"Pain"},{"key":"1310_CR3","doi-asserted-by":"publisher","unstructured":"Headache Classification Committee of the International Headache Society (IHS). The international classification of headache disorders, 3rd edition (in eng). Cephalalgia. 2018;38(1):1\u2013211. https:\/\/doi.org\/10.1177\/0333102417738202.","DOI":"10.1177\/0333102417738202"},{"issue":"1","key":"1310_CR4","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s10194-019-0969-0","volume":"20","author":"G Di Stefano","year":"2019","unstructured":"Di Stefano G, Maarbjerg S, Truini A. Trigeminal neuralgia secondary to multiple sclerosis: from the clinical picture to the treatment options (in eng). J Headache Pain. 2019;20(1):20. https:\/\/doi.org\/10.1186\/s10194-019-0969-0.","journal-title":"J Headache Pain"},{"issue":"6","key":"1310_CR5","doi-asserted-by":"publisher","first-page":"355","DOI":"10.3949\/ccjm.90a.22052","volume":"90","author":"MS Chong","year":"2023","unstructured":"Chong MS, Bahra A, Zakrzewska JM. Guidelines for the management of trigeminal neuralgia (in eng). Cleve Clin J Med. 2023;90(6):355\u201362. https:\/\/doi.org\/10.3949\/ccjm.90a.22052.","journal-title":"Cleve Clin J Med"},{"issue":"1","key":"1310_CR6","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41572-024-00523-z","volume":"10","author":"S Ashina","year":"2024","unstructured":"Ashina S, et al. Trigeminal neuralgia (in eng). Nat Rev Dis Primers. 2024;10(1):39. https:\/\/doi.org\/10.1038\/s41572-024-00523-z.","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"1310_CR7","doi-asserted-by":"publisher","first-page":"109","DOI":"10.2174\/1570159x17666191010094350","volume":"18","author":"EI Araya","year":"2020","unstructured":"Araya EI, Claudino RF, Piovesan EJ, Chichorro JG. Trigeminal neuralgia: basic and clinical aspects (in eng). Curr Neuropharmacol. 2020;18(2):109\u201319. https:\/\/doi.org\/10.2174\/1570159x17666191010094350.","journal-title":"Curr Neuropharmacol"},{"issue":"1","key":"1310_CR8","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3988\/jcn.2025.0433","volume":"22","author":"YD Jeong","year":"2026","unstructured":"Jeong YD, et al. Global incidence and prevalence of trigeminal neuralgia, 1945\u20132024: a systematic review and meta-regression analysis (in eng). J Clin Neurol. 2026;22(1):102\u201312. https:\/\/doi.org\/10.3988\/jcn.2025.0433.","journal-title":"J Clin Neurol"},{"issue":"1","key":"1310_CR9","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1124\/jpet.106.101402","volume":"318","author":"JA Kim","year":"2006","unstructured":"Kim JA, Park JY, Kang HW, Huh SU, Jeong SW, Lee JH. Augmentation of Cav3.2 T-type calcium channel activity by cAMP-dependent protein kinase A (in eng). J Pharmacol Exp Ther. 2006;318(1):230\u20137. https:\/\/doi.org\/10.1124\/jpet.106.101402.","journal-title":"J Pharmacol Exp Ther"},{"key":"1310_CR10","doi-asserted-by":"publisher","unstructured":"Ramacciotti AS, Soares BG, Atallah AN. Dipyrone for acute primary headaches (in eng). Cochrane Database Syst Rev. 2007;(2):Cd004842. https:\/\/doi.org\/10.1002\/14651858.CD004842.pub2.","DOI":"10.1002\/14651858.CD004842.pub2"},{"issue":"7","key":"1310_CR11","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.adaj.2016.02.014","volume":"147","author":"IP De Toledo","year":"2016","unstructured":"De Toledo IP, et al. Prevalence of trigeminal neuralgia: a systematic review (in eng). J Am Dent Assoc. 2016;147(7):570-576.e2. https:\/\/doi.org\/10.1016\/j.adaj.2016.02.014.","journal-title":"J Am Dent Assoc"},{"issue":"2","key":"1310_CR12","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3171\/2025.8.peds25318","volume":"37","author":"A Wadhwa","year":"2025","unstructured":"Wadhwa A, Purohit S, Taussky P, Ogilvy CS. Epidemiological and demographic patterns of pediatric trigeminal neuralgia: nationwide trends in diagnosis and treatment over a decade (in eng). J Neurosurg Pediatr. 2025;37(2):157\u201363. https:\/\/doi.org\/10.3171\/2025.8.peds25318.","journal-title":"J Neurosurg Pediatr"},{"key":"1310_CR13","doi-asserted-by":"publisher","first-page":"174480692090189","DOI":"10.1177\/1744806920901890","volume":"16","author":"E Gambeta","year":"2020","unstructured":"Gambeta E, Chichorro JG, Zamponi GW. Trigeminal neuralgia: an overview from pathophysiology to pharmacological treatments (in eng). Mol Pain. 2020;16:1744806920901890. https:\/\/doi.org\/10.1177\/1744806920901890.","journal-title":"Mol Pain"},{"issue":"Pt 12","key":"1310_CR14","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1093\/brain\/124.12.2347","volume":"124","author":"S Love","year":"2001","unstructured":"Love S, Coakham HB. Trigeminal neuralgia: pathology and pathogenesis (in eng). Brain. 2001;124(Pt 12):2347\u201360. https:\/\/doi.org\/10.1093\/brain\/124.12.2347.","journal-title":"Brain"},{"key":"1310_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2020.106397","volume":"200","author":"CA Smith","year":"2021","unstructured":"Smith CA, Paskhover B, Mammis A. Molecular mechanisms of trigeminal neuralgia: a systematic review (in eng). Clin Neurol Neurosurg. 2021;200:106397. https:\/\/doi.org\/10.1016\/j.clineuro.2020.106397.","journal-title":"Clin Neurol Neurosurg"},{"issue":"11","key":"1310_CR16","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.97572","volume":"17","author":"A Kempa","year":"2025","unstructured":"Kempa A, Sinou N, Filippou D, Shihada A. Anatomical variations of the foramen ovale and trigeminal neuralgia (in eng). Cureus. 2025;17(11):e97572. https:\/\/doi.org\/10.7759\/cureus.97572.","journal-title":"Cureus"},{"issue":"1","key":"1310_CR17","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1097\/00002508-200201000-00002","volume":"18","author":"M Devor","year":"2002","unstructured":"Devor M, Amir R, Rappaport ZH. Pathophysiology of trigeminal neuralgia: the ignition hypothesis (in eng). Clin J Pain. 2002;18(1):4\u201313. https:\/\/doi.org\/10.1097\/00002508-200201000-00002.","journal-title":"Clin J Pain"},{"issue":"1","key":"1310_CR18","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12893-025-02762-7","volume":"25","author":"II Okon","year":"2025","unstructured":"Okon II, et al. Microvascular decompression: a contemporary update (in eng). BMC Surg. 2025;25(1):20. https:\/\/doi.org\/10.1186\/s12893-025-02762-7.","journal-title":"BMC Surg"},{"issue":"6","key":"1310_CR19","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.3171\/2014.11.jns141741","volume":"123","author":"AL Ko","year":"2015","unstructured":"Ko AL, Lee A, Raslan AM, Ozpinar A, McCartney S, Burchiel KJ. Trigeminal neuralgia without neurovascular compression presents earlier than trigeminal neuralgia with neurovascular compression (in eng). J Neurosurg. 2015;123(6):1519\u201327. https:\/\/doi.org\/10.3171\/2014.11.jns141741.","journal-title":"J Neurosurg"},{"issue":"2","key":"1310_CR20","doi-asserted-by":"publisher","first-page":"138","DOI":"10.4103\/ijp.ijp_296_19","volume":"54","author":"S Gupta","year":"2022","unstructured":"Gupta S, Bansal RN, Singh Sodhi SP, Brar GK. Animal models\u2014mimicking the pain of trigeminal neuralgia (in eng). Indian J Pharmacol. 2022;54(2):138\u201345. https:\/\/doi.org\/10.4103\/ijp.ijp_296_19.","journal-title":"Indian J Pharmacol"},{"key":"1310_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci13030390","author":"S Liu","year":"2023","unstructured":"Liu S, Crawford J, Tao F. Assessing orofacial pain behaviors in animal models: a review (in eng). Brain Sci. 2023. https:\/\/doi.org\/10.3390\/brainsci13030390.","journal-title":"Brain Sci"},{"issue":"4","key":"1310_CR22","doi-asserted-by":"publisher","first-page":"e382","DOI":"10.4317\/jced.55429","volume":"11","author":"M Mart\u00ednez-Garc\u00eda","year":"2019","unstructured":"Mart\u00ednez-Garc\u00eda M, Miguel\u00e1\u00f1ez-Medr\u00e1n BC, Goicoechea C. Animal models in the study and treatment of orofacial pain (in eng). J Clin Exp Dent. 2019;11(4):e382\u201390. https:\/\/doi.org\/10.4317\/jced.55429.","journal-title":"J Clin Exp Dent"},{"issue":"1","key":"1310_CR23","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s10194-023-01580-7","volume":"24","author":"X Zeng","year":"2023","unstructured":"Zeng X, Mai J, Xie H, Yang L, Liu X. Activation of CB1R alleviates central sensitization by regulating HCN2-pNR2B signaling in a chronic migraine rat model (in eng). J Headache Pain. 2023;24(1):44. https:\/\/doi.org\/10.1186\/s10194-023-01580-7.","journal-title":"J Headache Pain"},{"key":"1310_CR24","doi-asserted-by":"publisher","unstructured":"Xu W, Zhang J, Wang Y, Wang L, Wang X. Changes in the expression of voltage-gated sodium channels Nav1.3, Nav1.7, Nav1.8, and Nav1.9 in rat trigeminal ganglia following chronic constriction injury (in eng). Neuroreport. 2016;27(12):929\u201334. https:\/\/doi.org\/10.1097\/wnr.0000000000000632.","DOI":"10.1097\/wnr.0000000000000632"},{"key":"1310_CR25","doi-asserted-by":"publisher","unstructured":"Siqueira SR, Alves B, Malpartida HM, Teixeira MJ, Siqueira JT. Abnormal expression of voltage-gated sodium channels Nav1.7, Nav1.3 and Nav1.8 in trigeminal neuralgia (in eng). Neuroscience. 2009;164(2):573\u20137. https:\/\/doi.org\/10.1016\/j.neuroscience.2009.08.037.","DOI":"10.1016\/j.neuroscience.2009.08.037"},{"key":"1310_CR26","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12990-015-0076-4","volume":"11","author":"AP Luiz","year":"2015","unstructured":"Luiz AP, Kopach O, Santana-Varela S, Wood JN. The role of Nav1.9 channel in the development of neuropathic orofacial pain associated with trigeminal neuralgia (in eng). Mol Pain. 2015;11:72. https:\/\/doi.org\/10.1186\/s12990-015-0076-4.","journal-title":"Mol Pain"},{"issue":"3","key":"1310_CR27","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1097\/j.pain.0000000000003053","volume":"165","author":"SI Loya-Lopez","year":"2024","unstructured":"Loya-Lopez SI, et al. Intranasal CRMP2-Ubc9 inhibitor regulates Na V 1.7 to alleviate trigeminal neuropathic pain (in eng). Pain. 2024;165(3):573\u201388. https:\/\/doi.org\/10.1097\/j.pain.0000000000003053.","journal-title":"Pain"},{"key":"1310_CR28","doi-asserted-by":"publisher","DOI":"10.1172\/jci177429","author":"C Tang","year":"2024","unstructured":"Tang C, et al. C2230, a preferential use- and state-dependent CaV2.2 channel blocker, mitigates pain behaviors across multiple pain models (in eng). J Clin Invest. 2024. https:\/\/doi.org\/10.1172\/jci177429.","journal-title":"J Clin Invest"},{"issue":"12","key":"1310_CR29","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1097\/j.pain.0000000000002651","volume":"163","author":"E Gambeta","year":"2022","unstructured":"Gambeta E, Gandini MA, Souza IA, Zamponi GW. Ca V 3.2 calcium channels contribute to trigeminal neuralgia (in eng). Pain. 2022;163(12):2315\u201325. https:\/\/doi.org\/10.1097\/j.pain.0000000000002651.","journal-title":"Pain"},{"key":"1310_CR30","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.neulet.2017.11.026","volume":"664","author":"J Ling","year":"2018","unstructured":"Ling J, Erol F, Gu JG. Role of KCNQ2 channels in orofacial cold sensitivity: KCNQ2 upregulation in trigeminal ganglion neurons after infraorbital nerve chronic constrictive injury (in eng). Neurosci Lett. 2018;664:84\u201390. https:\/\/doi.org\/10.1016\/j.neulet.2017.11.026.","journal-title":"Neurosci Lett"},{"key":"1310_CR31","doi-asserted-by":"publisher","first-page":"174480692110161","DOI":"10.1177\/17448069211016139","volume":"17","author":"MA Mannerak","year":"2021","unstructured":"Mannerak MA, Lashkarivand A, Eide PK. Trigeminal neuralgia and genetics: a systematic review (in eng). Mol Pain. 2021;17:17448069211016140. https:\/\/doi.org\/10.1177\/17448069211016139.","journal-title":"Mol Pain"},{"issue":"5","key":"1310_CR32","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1097\/j.pain.0000000000002804","volume":"164","author":"J Thuraiaiyah","year":"2023","unstructured":"Thuraiaiyah J, Al-Karagholi MA, Elbahi FA, Zhuang ZA, Ashina M. Adenosine causes short-lasting vasodilation and headache but not migraine attacks in migraine patients: a randomized clinical trial (in eng). Pain. 2023;164(5):1118\u201327. https:\/\/doi.org\/10.1097\/j.pain.0000000000002804.","journal-title":"Pain"},{"issue":"9","key":"1310_CR33","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1212\/01.wnl.0000269670.30045.6b","volume":"69","author":"M Obermann","year":"2007","unstructured":"Obermann M, et al. Impaired trigeminal nociceptive processing in patients with trigeminal neuralgia (in eng). Neurology. 2007;69(9):835\u201341. https:\/\/doi.org\/10.1212\/01.wnl.0000269670.30045.6b.","journal-title":"Neurology"},{"issue":"8","key":"1310_CR34","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1007\/s00701-019-03981-7","volume":"161","author":"E Mazzucchi","year":"2019","unstructured":"Mazzucchi E, Brinzeu A, Sindou M. Arachnoiditis as an outcome factor for microvascular decompression in classical trigeminal neuralgia (in eng). Acta Neurochir (Wien). 2019;161(8):1589\u201398. https:\/\/doi.org\/10.1007\/s00701-019-03981-7.","journal-title":"Acta Neurochir (Wien)"},{"issue":"6","key":"1310_CR35","doi-asserted-by":"publisher","DOI":"10.1097\/pr9.0000000000001117","volume":"8","author":"C Ostertag","year":"2023","unstructured":"Ostertag C, Friedman TN, Keough MB, Kerr BJ, Sankar T. Heightened presence of inflammatory mediators in the cerebrospinal fluid of patients with trigeminal neuralgia (in eng). Pain Rep. 2023;8(6):e1117. https:\/\/doi.org\/10.1097\/pr9.0000000000001117.","journal-title":"Pain Rep"},{"issue":"6","key":"1310_CR36","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1002\/ejp.2231","volume":"28","author":"MS Lafta","year":"2024","unstructured":"Lafta MS, Sokolov AV, Landtblom AM, Ericson H, Schi\u00f6th HB, Abu Hamdeh S. Exploring biomarkers in trigeminal neuralgia patients operated with microvascular decompression: a comparison with multiple sclerosis patients and non-neurological controls (in eng). Eur J Pain. 2024;28(6):929\u201342. https:\/\/doi.org\/10.1002\/ejp.2231.","journal-title":"Eur J Pain"},{"key":"1310_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10050998","author":"T Svedung Wettervik","year":"2022","unstructured":"Svedung Wettervik T, et al. Cerebrospinal fluid in classical trigeminal neuralgia: an exploratory study on candidate biomarkers (in eng). Biomedicines. 2022. https:\/\/doi.org\/10.3390\/biomedicines10050998.","journal-title":"Biomedicines"},{"issue":"4","key":"1310_CR38","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1080\/01616412.2018.1564188","volume":"41","author":"MX Liu","year":"2019","unstructured":"Liu MX, Zhong J, Xia L, Dou NN, Li ST. A correlative analysis between inflammatory cytokines and trigeminal neuralgia or hemifacial spasm (in eng). Neurol Res. 2019;41(4):335\u201340. https:\/\/doi.org\/10.1080\/01616412.2018.1564188.","journal-title":"Neurol Res"},{"issue":"1","key":"1310_CR39","first-page":"46","volume":"10","author":"YF Zhao","year":"2001","unstructured":"Zhao YF, Jiang XZ, Hu SH, Liu Y, Miao L, Song CY. Observation of plasma levels of beta-endorphin in patients with trigeminal neuralgia (in chi). Shanghai Kou Qiang Yi Xue. 2001;10(1):46\u20138.","journal-title":"Shanghai Kou Qiang Yi Xue"},{"key":"1310_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/molecules30091884","author":"C Demartini","year":"2025","unstructured":"Demartini C, et al. Insights into the involvement of TRPA1 channels in the neuro-inflammatory machinery of trigeminal neuralgia (in eng). Molecules. 2025. https:\/\/doi.org\/10.3390\/molecules30091884.","journal-title":"Molecules"},{"issue":"8","key":"1310_CR41","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1177\/0333102419897623","volume":"40","author":"G Di Stefano","year":"2020","unstructured":"Di Stefano G, Yuan JH, Cruccu G, Waxman SG, Dib-Hajj SD, Truini A. Familial trigeminal neuralgia\u2014a systematic clinical study with a genomic screen of the neuronal electrogenisome (in eng). Cephalalgia. 2020;40(8):767\u201377. https:\/\/doi.org\/10.1177\/0333102419897623.","journal-title":"Cephalalgia"},{"key":"1310_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19113320","author":"C Demartini","year":"2018","unstructured":"Demartini C, et al. Antagonism of transient receptor potential ankyrin type-1 channels as a potential target for the treatment of trigeminal neuropathic pain: study in an animal model (in eng). Int J Mol Sci. 2018. https:\/\/doi.org\/10.3390\/ijms19113320.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"1310_CR43","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1093\/pm\/pnaa028","volume":"21","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Lian Y, Zhang H, Xie N, Chen Y. CGRP plasma levels decrease in classical trigeminal neuralgia patients treated with botulinum toxin type A: a pilot study (in eng). Pain Med. 2020;21(8):1611\u20135. https:\/\/doi.org\/10.1093\/pm\/pnaa028.","journal-title":"Pain Med"},{"key":"1310_CR44","doi-asserted-by":"publisher","DOI":"10.1515\/jbcpp-2019-0274","author":"I Joshi","year":"2020","unstructured":"Joshi I, Mattoo B, Mohan VK, Bhatia R. Aberrant pain modulation in trigeminal neuralgia patients (in eng). J Basic Clin Physiol Pharmacol. 2020. https:\/\/doi.org\/10.1515\/jbcpp-2019-0274.","journal-title":"J Basic Clin Physiol Pharmacol"},{"issue":"1","key":"1310_CR45","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1002\/ejp.1293","volume":"23","author":"A G\u00fcnd\u00fcz","year":"2019","unstructured":"G\u00fcnd\u00fcz A, et al. Reduced inhibition in brainstem circuits in classical trigeminal neuralgia (in eng). Eur J Pain. 2019;23(1):142\u20139. https:\/\/doi.org\/10.1002\/ejp.1293.","journal-title":"Eur J Pain"},{"key":"1310_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2023.114789","volume":"459","author":"F Fiatcoski","year":"2024","unstructured":"Fiatcoski F, Jesus CHA, de Melo Turnes J, Chichorro JG, Kopruszinski CM. Sex differences in descending control of nociception (DCN) responses after chronic orofacial pain induction in rats and the contribution of kappa opioid receptors (in eng). Behav Brain Res. 2024;459:114789. https:\/\/doi.org\/10.1016\/j.bbr.2023.114789.","journal-title":"Behav Brain Res"},{"issue":"4","key":"1310_CR47","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s00482-024-00810-4","volume":"38","author":"R Ruscheweyh","year":"2024","unstructured":"Ruscheweyh R, Gierthm\u00fchlen J, Hedderich DM, Go\u00dfrau G, Leis S. Trigeminal neuralgia: drug therapy: the new German guideline (in ger). Schmerz. 2024;38(4):283\u201392. https:\/\/doi.org\/10.1007\/s00482-024-00810-4. (Medikament\u00f6seTherapiederTrigeminusneuralgie:DieneueLeitlinie).","journal-title":"Schmerz"},{"issue":"6","key":"1310_CR48","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1111\/ene.13950","volume":"26","author":"L Bendtsen","year":"2019","unstructured":"Bendtsen L, et al. European Academy of Neurology guideline on trigeminal neuralgia (in eng). Eur J Neurol. 2019;26(6):831\u201349. https:\/\/doi.org\/10.1111\/ene.13950.","journal-title":"Eur J Neurol"},{"issue":"10","key":"1310_CR49","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1111\/j.1468-1331.2008.02185.x","volume":"15","author":"G Cruccu","year":"2008","unstructured":"Cruccu G, et al. AAN-EFNS guidelines on trigeminal neuralgia management (in eng). Eur J Neurol. 2008;15(10):1013\u201328. https:\/\/doi.org\/10.1111\/j.1468-1331.2008.02185.x.","journal-title":"Eur J Neurol"},{"issue":"1","key":"1310_CR50","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1129-2377-15-34","volume":"15","author":"G Di Stefano","year":"2014","unstructured":"Di Stefano G, La Cesa S, Truini A, Cruccu G. Natural history and outcome of 200 outpatients with classical trigeminal neuralgia treated with carbamazepine or oxcarbazepine in a tertiary centre for neuropathic pain (in eng). J Headache Pain. 2014;15(1):34. https:\/\/doi.org\/10.1186\/1129-2377-15-34.","journal-title":"J Headache Pain"},{"issue":"5","key":"1310_CR51","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1002\/ejp.1727","volume":"25","author":"G Di Stefano","year":"2021","unstructured":"Di Stefano G, et al. Real-world effectiveness and tolerability of carbamazepine and oxcarbazepine in 354 patients with trigeminal neuralgia (in eng). Eur J Pain. 2021;25(5):1064\u201371. https:\/\/doi.org\/10.1002\/ejp.1727.","journal-title":"Eur J Pain"},{"key":"1310_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/medicines13010003","author":"M Pinto Moreira","year":"2026","unstructured":"Pinto Moreira M, Carneiro BD, Faria CS, Pozza DH, Fonseca S. Anticonvulsant therapy in trigeminal neuralgia: a class-oriented systematic review (in eng). Medicines (Basel). 2026. https:\/\/doi.org\/10.3390\/medicines13010003.","journal-title":"Medicines (Basel)"},{"issue":"1\u20132","key":"1310_CR53","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.eplepsyres.2013.08.013","volume":"107","author":"A Fortuna","year":"2013","unstructured":"Fortuna A, Alves G, Soares-da-Silva P, Falc\u00e3o A. Pharmacokinetics, brain distribution and plasma protein binding of carbamazepine and nine derivatives: new set of data for predictive in silico ADME models (in eng). Epilepsy Res. 2013;107(1\u20132):37\u201350. https:\/\/doi.org\/10.1016\/j.eplepsyres.2013.08.013.","journal-title":"Epilepsy Res"},{"issue":"3","key":"1310_CR54","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.yebeh.2006.04.022","volume":"9","author":"W Martinez","year":"2006","unstructured":"Martinez W, Ingenito A, Blakeslee M, Barkley GL, McCague K, D\u2019Souza J. Efficacy, safety, and tolerability of oxcarbazepine monotherapy (in eng). Epilepsy Behav. 2006;9(3):448\u201356. https:\/\/doi.org\/10.1016\/j.yebeh.2006.04.022.","journal-title":"Epilepsy Behav"},{"key":"1310_CR55","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.physbeh.2018.04.025","volume":"191","author":"E Gambeta","year":"2018","unstructured":"Gambeta E, Batista MA, Maschio GP, Turnes JM, Araya EI, Chichorro JG. Anxiety- but not depressive-like behaviors are related to facial hyperalgesia in a model of trigeminal neuropathic pain in rats (in eng). Physiol Behav. 2018;191:131\u20137. https:\/\/doi.org\/10.1016\/j.physbeh.2018.04.025.","journal-title":"Physiol Behav"},{"issue":"2","key":"1310_CR56","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/s0304-3959(97)00104-8","volume":"73","author":"JM Zakrzewska","year":"1997","unstructured":"Zakrzewska JM, Chaudhry Z, Nurmikko TJ, Patton DW, Mullens LE. Lamotrigine (lamictal) in refractory trigeminal neuralgia: results from a double-blind placebo controlled crossover trial (in eng). Pain. 1997;73(2):223\u201330. https:\/\/doi.org\/10.1016\/s0304-3959(97)00104-8.","journal-title":"Pain"},{"issue":"4","key":"1310_CR57","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s12663-013-0513-8","volume":"13","author":"A Rustagi","year":"2014","unstructured":"Rustagi A, Roychoudhury A, Bhutia O, Trikha A, Srivastava MV. Lamotrigine versus pregabalin in the management of refractory trigeminal neuralgia: a randomized open label crossover trial (in eng). J Maxillofac Oral Surg. 2014;13(4):409\u201318. https:\/\/doi.org\/10.1007\/s12663-013-0513-8.","journal-title":"J Maxillofac Oral Surg"},{"issue":"6","key":"1310_CR58","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.jcma.2011.04.002","volume":"74","author":"S Shaikh","year":"2011","unstructured":"Shaikh S, Yaacob HB, Abd Rahman RB. Lamotrigine for trigeminal neuralgia: efficacy and safety in comparison with carbamazepine (in eng). J Chin Med Assoc. 2011;74(6):243\u20139. https:\/\/doi.org\/10.1016\/j.jcma.2011.04.002.","journal-title":"J Chin Med Assoc"},{"key":"1310_CR59","doi-asserted-by":"publisher","first-page":"1651898","DOI":"10.3389\/fphar.2025.1651898","volume":"16","author":"HA Alhaj","year":"2025","unstructured":"Alhaj HA, Samara J, Alnamous A, Karima R, Saber-Ayad M. Advancing drug safety in psychiatry: insights from pharmacogenomics of hypersensitivity reactions (in eng). Front Pharmacol. 2025;16:1651898. https:\/\/doi.org\/10.3389\/fphar.2025.1651898.","journal-title":"Front Pharmacol"},{"key":"1310_CR60","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.2147\/ndt.s407543","volume":"19","author":"G De Stefano","year":"2023","unstructured":"De Stefano G, Di Pietro G, Truini A, Cruccu G, Di Stefano G. Considerations when using gabapentinoids to treat trigeminal neuralgia: a review (in eng). Neuropsychiatr Dis Treat. 2023;19:2007\u201312. https:\/\/doi.org\/10.2147\/ndt.s407543.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"1310_CR61","doi-asserted-by":"publisher","first-page":"1045640","DOI":"10.3389\/fneur.2023.1045640","volume":"14","author":"X Zhao","year":"2023","unstructured":"Zhao X, Ge S. The efficacy and safety of gabapentin vs. carbamazepine in patients with primary trigeminal neuralgia: a systematic review and meta-analysis (in eng). Front Neurol. 2023;14:1045640. https:\/\/doi.org\/10.3389\/fneur.2023.1045640.","journal-title":"Front Neurol"},{"issue":"7","key":"1310_CR62","doi-asserted-by":"publisher","DOI":"10.1098\/rsob.250013","volume":"15","author":"AC Dolphin","year":"2025","unstructured":"Dolphin AC. Biochemistry and physiology of voltage-gated calcium channel trafficking: a target for gabapentinoid drugs (in eng). Open Biol. 2025;15(7):250013. https:\/\/doi.org\/10.1098\/rsob.250013.","journal-title":"Open Biol"},{"key":"1310_CR63","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3389\/fncel.2020.00083","volume":"14","author":"SRA Alles","year":"2020","unstructured":"Alles SRA, Cain SM, Snutch TP. Pregabalin as a pain therapeutic: beyond calcium channels (in eng). Front Cell Neurosci. 2020;14:83. https:\/\/doi.org\/10.3389\/fncel.2020.00083.","journal-title":"Front Cell Neurosci"},{"issue":"2","key":"1310_CR64","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1177\/2049463720912496","volume":"14","author":"M Chincholkar","year":"2020","unstructured":"Chincholkar M. Gabapentinoids: pharmacokinetics, pharmacodynamics and considerations for clinical practice (in eng). Br J Pain. 2020;14(2):104\u201314. https:\/\/doi.org\/10.1177\/2049463720912496.","journal-title":"Br J Pain"},{"issue":"2","key":"1310_CR65","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/jnc.14627","volume":"148","author":"Y Chen","year":"2019","unstructured":"Chen Y, Chen SR, Chen H, Zhang J, Pan HL. Increased \u03b12\u03b4-1-NMDA receptor coupling potentiates glutamatergic input to spinal dorsal horn neurons in chemotherapy-induced neuropathic pain (in eng). J Neurochem. 2019;148(2):252\u201374. https:\/\/doi.org\/10.1111\/jnc.14627.","journal-title":"J Neurochem"},{"issue":"9","key":"1310_CR66","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1016\/j.celrep.2018.02.021","volume":"22","author":"J Chen","year":"2018","unstructured":"Chen J, et al. The \u03b12\u03b4-1-NMDA receptor complex is critically involved in neuropathic pain development and gabapentin therapeutic actions (in eng). Cell Rep. 2018;22(9):2307\u201321. https:\/\/doi.org\/10.1016\/j.celrep.2018.02.021.","journal-title":"Cell Rep"},{"issue":"4","key":"1310_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110308","volume":"38","author":"J Chen","year":"2022","unstructured":"Chen J, et al. The \u03b12\u03b4-1-NMDA receptor complex is critically involved in neuropathic pain development and gabapentin therapeutic actions (in eng). Cell Rep. 2022;38(4):110308. https:\/\/doi.org\/10.1016\/j.celrep.2022.110308.","journal-title":"Cell Rep"},{"issue":"11","key":"1310_CR68","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1212\/wnl.37.11.1725","volume":"37","author":"GH Fromm","year":"1987","unstructured":"Fromm GH, Terrence CF. Comparison of L-baclofen and racemic baclofen in trigeminal neuralgia (in eng). Neurology. 1987;37(11):1725\u20138. https:\/\/doi.org\/10.1212\/wnl.37.11.1725.","journal-title":"Neurology"},{"issue":"3","key":"1310_CR69","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1002\/ana.410150306","volume":"15","author":"GH Fromm","year":"1984","unstructured":"Fromm GH, Terrence CF, Chattha AS. Baclofen in the treatment of trigeminal neuralgia: double-blind study and long-term follow-up (in eng). Ann Neurol. 1984;15(3):240\u20134. https:\/\/doi.org\/10.1002\/ana.410150306.","journal-title":"Ann Neurol"},{"issue":"1","key":"1310_CR70","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1159\/000115677","volume":"23","author":"L Steardo","year":"1984","unstructured":"Steardo L, Leo A, Marano E. Efficacy of baclofen in trigeminal neuralgia and some other painful conditions. A clinical trial (in eng). Eur Neurol. 1984;23(1):51\u20135. https:\/\/doi.org\/10.1159\/000115677.","journal-title":"Eur Neurol"},{"issue":"4","key":"1310_CR71","first-page":"109","volume":"1","author":"BS Parmar","year":"1989","unstructured":"Parmar BS, Shah KH, Gandhi IC. Baclofen in trigeminal neuralgia\u2014a clinical trial (in eng). Indian J Dent Res. 1989;1(4):109\u201313.","journal-title":"Indian J Dent Res"},{"issue":"Suppl 3","key":"1310_CR72","doi-asserted-by":"publisher","first-page":"S2197","DOI":"10.4103\/jpbs.jpbs_139_24","volume":"16","author":"NC Sangamesh","year":"2024","unstructured":"Sangamesh NC, Bajoria AA, Mishra S, Behera S, Sahoo SK, Bal PK. Comparative assessment of the effectiveness of carbamazepine and baclofen in the management of trigeminal neuralgia (in eng). J Pharm Bioallied Sci. 2024;16(Suppl 3):S2197-s2198. https:\/\/doi.org\/10.4103\/jpbs.jpbs_139_24.","journal-title":"J Pharm Bioallied Sci"},{"issue":"1\u20132","key":"1310_CR73","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1615\/CritRevPhysRehabilMed.2013007945","volume":"25","author":"E Chang","year":"2013","unstructured":"Chang E, Ghosh N, Yanni D, Lee S, Alexandru D, Mozaffar T. A review of spasticity treatments: pharmacological and interventional approaches (in eng). Crit Rev Phys Rehabil Med. 2013;25(1\u20132):11\u201322. https:\/\/doi.org\/10.1615\/CritRevPhysRehabilMed.2013007945.","journal-title":"Crit Rev Phys Rehabil Med"},{"issue":"9","key":"1310_CR74","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.34835","volume":"7","author":"BJ Oldfield","year":"2024","unstructured":"Oldfield BJ, et al. Long-term use of muscle relaxant medications for chronic pain: a systematic review (in eng). JAMA Netw Open. 2024;7(9):e2434835. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.34835.","journal-title":"JAMA Netw Open"},{"issue":"2","key":"1310_CR75","doi-asserted-by":"publisher","first-page":"e385","DOI":"10.1016\/j.bja.2019.05.026","volume":"123","author":"D Moore","year":"2019","unstructured":"Moore D, Chong MS, Shetty A, Zakrzewska JM. A systematic review of rescue analgesic strategies in acute exacerbations of primary trigeminal neuralgia (in eng). Br J Anaesth. 2019;123(2):e385\u201396. https:\/\/doi.org\/10.1016\/j.bja.2019.05.026.","journal-title":"Br J Anaesth"},{"issue":"5","key":"1310_CR76","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1097\/WNF.0b013e31829cb60e","volume":"36","author":"C Z\u00fa\u00f1iga","year":"2013","unstructured":"Z\u00fa\u00f1iga C, Piedimonte F, D\u00edaz S, Micheli F. Acute treatment of trigeminal neuralgia with onabotulinum toxin A (in eng). Clin Neuropharmacol. 2013;36(5):146\u201350. https:\/\/doi.org\/10.1097\/WNF.0b013e31829cb60e.","journal-title":"Clin Neuropharmacol"},{"key":"1310_CR77","doi-asserted-by":"publisher","DOI":"10.3390\/toxins17070314","author":"PA Sampaio Rocha-Filho","year":"2025","unstructured":"Sampaio Rocha-Filho PA, Dominguez M, Robinson CL, Ashina S. Uses of botulinum toxin in headache and facial pain disorders: an update (in eng). Toxins (Basel). 2025. https:\/\/doi.org\/10.3390\/toxins17070314.","journal-title":"Toxins (Basel)"},{"issue":"2","key":"1310_CR78","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1111\/head.14903","volume":"65","author":"M Romozzi","year":"2025","unstructured":"Romozzi M, et al. Pharmacological differences and switching among anti-CGRP monoclonal antibodies: a narrative review (in eng). Headache. 2025;65(2):342\u201352. https:\/\/doi.org\/10.1111\/head.14903.","journal-title":"Headache"},{"issue":"11","key":"1310_CR79","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/S1474-4422(22)00294-0","volume":"21","author":"AS Schott Andersen","year":"2022","unstructured":"Schott Andersen AS, et al. Safety and efficacy of erenumab in patients with trigeminal neuralgia in Denmark: a double-blind, randomised, placebo-controlled, proof-of-concept study (in eng). The Lancet Neurol. 2022;21(11):994\u20131003. https:\/\/doi.org\/10.1016\/S1474-4422(22)00294-0.","journal-title":"The Lancet Neurol"},{"issue":"3","key":"1310_CR80","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1212\/CPJ.0000000000001075","volume":"11","author":"E Parascandolo","year":"2021","unstructured":"Parascandolo E, Levinson K, Rizzoli P, Sharon R. Efficacy of erenumab in the treatment of trigeminal neuralgia: a retrospective case series (in eng). Neurology Clin Pract. 2021;11(3):227\u201331. https:\/\/doi.org\/10.1212\/CPJ.0000000000001075.","journal-title":"Neurology Clin Pract"},{"issue":"3","key":"1310_CR81","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.35913","volume":"15","author":"M Katsuki","year":"2023","unstructured":"Katsuki M, Kawamura S, Kashiwagi K, Tachikawa S, Koh A. Erenumab in the treatment of comorbid trigeminal neuralgia in patients with migraine (in eng). Cureus. 2023;15(3):e35913. https:\/\/doi.org\/10.7759\/cureus.35913.","journal-title":"Cureus"},{"key":"1310_CR82","doi-asserted-by":"publisher","unstructured":"Alc\u00e1ntara Montero A, S\u00e1nchez Carnerero CI. Eslicarbazepine acetate for neuropathic pain, headache, and cranial neuralgia: evidence and experience (in eng spa). Neurologia (Engl Ed). 2019;34(6):386\u2013395. https:\/\/doi.org\/10.1016\/j.nrl.2016.11.009. Acetato de eslicarbazepina en dolor neurop\u00e1tico, cefaleas y neuralgias craneales: Evidencia y experiencia.","DOI":"10.1016\/j.nrl.2016.11.009"},{"issue":"9","key":"1310_CR83","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.nrl.2019.10.001","volume":"35","author":"A Sanchez-Larsen","year":"2020","unstructured":"Sanchez-Larsen A, Sopelana D, Layos-Romero A, Segura T. Eslicarbazepine acetate for trigeminal neuralgia, (in eng, spa). Neurologia. 2020;35(9):669\u201370. https:\/\/doi.org\/10.1016\/j.nrl.2019.10.001.","journal-title":"Neurologia"},{"issue":"6","key":"1310_CR84","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1002\/ejp.1192","volume":"22","author":"A Sanchez-Larsen","year":"2018","unstructured":"Sanchez-Larsen A, et al. Assessment of efficacy and safety of eslicarbazepine acetate for the treatment of trigeminal neuralgia (in eng). Eur J Pain. 2018;22(6):1080\u20137. https:\/\/doi.org\/10.1002\/ejp.1192.","journal-title":"Eur J Pain"},{"issue":"9","key":"1310_CR85","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1111\/ene.13069","volume":"23","author":"B Berghuis","year":"2016","unstructured":"Berghuis B, de Haan GJ, van den Broek MPH, Sander JW, Lindhout D, Koeleman BPC. Epidemiology, pathophysiology and putative genetic basis of carbamazepine- and oxcarbazepine-induced hyponatremia (in eng). Eur J Neurol. 2016;23(9):1393\u20139. https:\/\/doi.org\/10.1111\/ene.13069.","journal-title":"Eur J Neurol"},{"issue":"5","key":"1310_CR86","doi-asserted-by":"publisher","first-page":"559","DOI":"10.3390\/medicina58050559","volume":"58","author":"J \u010ciau\u0161kait\u0117","year":"2022","unstructured":"\u010ciau\u0161kait\u0117 J, Gel\u017einien\u0117 G, Jurkevi\u010dien\u0117 G. Oxcarbazepine and hyponatremia (in eng). Medicina. 2022;58(5):559. https:\/\/doi.org\/10.3390\/medicina58050559.","journal-title":"Medicina"},{"issue":"1","key":"1310_CR87","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1002\/epi4.12814","volume":"9","author":"O Str\u00fd\u010dek","year":"2023","unstructured":"Str\u00fd\u010dek O, V\u0161iansk\u00fd V, Dole\u017ealov\u00e1 I, Ko\u010dvarov\u00e1 J, Pail M, Br\u00e1zdil M. Eslicarbazepine-induced hyponatremia: a retrospective single-center real clinical practice study. Epilepsia Open. 2023;9(1):404\u20138. https:\/\/doi.org\/10.1002\/epi4.12814.","journal-title":"Epilepsia Open"},{"key":"1310_CR88","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/nyas.12513","volume":"1329","author":"W Cawello","year":"2014","unstructured":"Cawello W, Stockis A, Andreas J-O, Dimova S. Advances in epilepsy treatment: lacosamide pharmacokinetic profile (in eng). Ann NY Acad Sci. 2014;1329:18\u201332. https:\/\/doi.org\/10.1111\/nyas.12513.","journal-title":"Ann NY Acad Sci"},{"key":"1310_CR89","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.119342","volume":"275","author":"A Carona","year":"2021","unstructured":"Carona A, Bicker J, Silva R, Fonseca C, Falc\u00e3o A, Fortuna A. Pharmacology of lacosamide: from its molecular mechanisms and pharmacokinetics to future therapeutic applications (in eng). Life Sci. 2021;275:119342. https:\/\/doi.org\/10.1016\/j.lfs.2021.119342.","journal-title":"Life Sci"},{"issue":"1","key":"1310_CR90","doi-asserted-by":"publisher","first-page":"119","DOI":"10.22514\/jofph.2025.011","volume":"39","author":"P Lappichetpaiboon","year":"2025","unstructured":"Lappichetpaiboon P, Tiamkao S, Ruangsri S, Paphangkorakit J, Pitiphat W, Jorns TP. Efficacy and safety of lacosamide in patients with trigeminal neuralgia: an 8-week pilot dose-escalation study (in eng). J Oral Facial Pain Headache. 2025;39(1):119\u201327. https:\/\/doi.org\/10.22514\/jofph.2025.011.","journal-title":"J Oral Facial Pain Headache"},{"issue":"4","key":"1310_CR91","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1111\/head.14505","volume":"63","author":"A Mu\u00f1oz-Vendrell","year":"2023","unstructured":"Mu\u00f1oz-Vendrell A, et al. Oral lacosamide for the treatment of refractory trigeminal neuralgia: a retrospective analysis of 86 cases (in eng). Headache. 2023;63(4):559\u201364. https:\/\/doi.org\/10.1111\/head.14505.","journal-title":"Headache"},{"issue":"7","key":"1310_CR92","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1111\/head.14952","volume":"65","author":"A Mu\u00f1oz-Vendrell","year":"2025","unstructured":"Mu\u00f1oz-Vendrell A, Val\u00edn-Villanueva P, Tena-Cucala R, Campoy S, Mart\u00ednez-Y\u00e9lamos S, Huerta-Villanueva M. Second-line pharmacological treatment strategies for trigeminal neuralgia: a retrospective comparison of lacosamide, gabapentin and baclofen (in eng). Headache. 2025;65(7):1116\u201323. https:\/\/doi.org\/10.1111\/head.14952.","journal-title":"Headache"},{"issue":"9","key":"1310_CR93","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1021\/acsmedchemlett.0c00263","volume":"11","author":"DR Witty","year":"2020","unstructured":"Witty DR, et al. Discovery of vixotrigine: a novel use-dependent sodium channel blocker for the treatment of trigeminal neuralgia (in eng). ACS Med Chem Lett. 2020;11(9):1678\u201387. https:\/\/doi.org\/10.1021\/acsmedchemlett.0c00263.","journal-title":"ACS Med Chem Lett"},{"issue":"1","key":"1310_CR94","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1124\/molpharm.120.000079","volume":"99","author":"CA Hinckley","year":"2021","unstructured":"Hinckley CA, et al. Characterization of vixotrigine, a broad-spectrum voltage-gated sodium channel blocker. Mol Pharmacol. 2021;99(1):49\u201359. https:\/\/doi.org\/10.1124\/molpharm.120.000079.","journal-title":"Mol Pharmacol"},{"issue":"1","key":"1310_CR95","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1002\/jcph.1298","volume":"59","author":"R Fong","year":"2019","unstructured":"Fong R, Ballow CH, Naik H, Steiner D, Palmer J, White WB. Effects of a state- and use-dependent Nav1.7 channel blocker on ambulatory blood pressure: a randomized, controlled crossover study (in eng). J Clin Pharmacol. 2019;59(1):90\u20137. https:\/\/doi.org\/10.1002\/jcph.1298.","journal-title":"J Clin Pharmacol"},{"issue":"4","key":"1310_CR96","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1111\/cts.12935","volume":"14","author":"H Naik","year":"2021","unstructured":"Naik H, Steiner DJ, Versavel M, Palmer J, Fong R. Safety, tolerability and pharmacokinetics of single and repeat doses of vixotrigine in healthy volunteers (in eng). Clin Transl Sci. 2021;14(4):1272\u20139. https:\/\/doi.org\/10.1111\/cts.12935.","journal-title":"Clin Transl Sci"},{"issue":"1","key":"1310_CR97","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/cpdd.739","volume":"9","author":"J Dunbar","year":"2020","unstructured":"Dunbar J, et al. Evaluation of the pharmacokinetic interaction between the voltage- and use-dependent Nav1.7 channel blocker vixotrigine and carbamazepine in healthy volunteers (in en). Clin Pharmacol Drug Dev. 2020;9(1):62\u201373. https:\/\/doi.org\/10.1002\/cpdd.739.","journal-title":"Clin Pharmacol Drug Dev"},{"issue":"8","key":"1310_CR98","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/s40261-020-00931-5","volume":"40","author":"Y Zhao","year":"2020","unstructured":"Zhao Y, Versavel M, Tidemann-Miller B, Christmann R, Naik H. Evaluation of the potential pharmacokinetic interactions between vixotrigine and an oral contraceptive (in eng). Clin Drug Investig. 2020;40(8):737\u201346. https:\/\/doi.org\/10.1007\/s40261-020-00931-5.","journal-title":"Clin Drug Investig"},{"issue":"4","key":"1310_CR99","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/S1474-4422(17)30005-4","volume":"16","author":"JM Zakrzewska","year":"2017","unstructured":"Zakrzewska JM, et al. Safety and efficacy of a Nav1.7 selective sodium channel blocker in patients with trigeminal neuralgia: a double-blind, placebo-controlled, randomised withdrawal phase 2a trial (in eng). The Lancet Neurol. 2017;16(4):291\u2013300. https:\/\/doi.org\/10.1016\/S1474-4422(17)30005-4.","journal-title":"The Lancet Neurol"},{"issue":"5","key":"1310_CR100","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1097\/01.jaa.0000000000000353","volume":"39","author":"E Weidman-Evans","year":"2026","unstructured":"Weidman-Evans E, Paquette R. What is the potential role of the nonopioid suzetrigine in pain management? Jaapa. 2026;39(5):14\u20137. https:\/\/doi.org\/10.1097\/01.jaa.0000000000000353.","journal-title":"Jaapa"},{"issue":"2","key":"1310_CR101","doi-asserted-by":"publisher","first-page":"95","DOI":"10.4103\/njs.NJS_8_18","volume":"24","author":"N Puri","year":"2018","unstructured":"Puri N, et al. A clinical study on comparative evaluation of the effectiveness of carbamazepine and combination of carbamazepine with baclofen or capsaicin in the management of trigeminal neuralgia (in eng). Niger J Surg Off Publ Niger Surg Res Soc. 2018;24(2):95\u20139. https:\/\/doi.org\/10.4103\/njs.NJS_8_18.","journal-title":"Niger J Surg Off Publ Niger Surg Res Soc"},{"issue":"5","key":"1310_CR102","doi-asserted-by":"publisher","first-page":"E541","DOI":"10.36076\/ppj.2020\/23\/E541","volume":"23","author":"D Goncalves","year":"2020","unstructured":"Goncalves D, Rebelo V, Barbosa P, Gomes A. 8% Capsaicin patch in treatment of peripheral neuropathic pain (in eng). Pain Phys. 2020;23(5):E541\u20138.","journal-title":"Pain Phys"},{"issue":"7","key":"1310_CR103","first-page":"457","volume":"19","author":"NA Elsheikh","year":"2016","unstructured":"Elsheikh NA, Amr YM. Calcitonin as an additive to local anesthetic and steroid injection using a modified coronoid approach in trigeminal neuralgia (in eng). Pain Physician. 2016;19(7):457\u201364.","journal-title":"Pain Physician"},{"issue":"4","key":"1310_CR104","doi-asserted-by":"publisher","first-page":"237","DOI":"10.14744\/agri.2021.26032","volume":"33","author":"S Balta","year":"2021","unstructured":"Balta S, K\u00f6knelTalu G. Clinical effectiveness of peripheral nerve blocks with lidocaine and corticosteroid in patients with trigeminal neuralgia (in eng). Agri: Agri (Algoloji) Dernegi\u2019nin Yayin Organidir = J Turk Soc Algol. 2021;33(4):237\u201342. https:\/\/doi.org\/10.14744\/agri.2021.26032.","journal-title":"Agri: Agri (Algoloji) Dernegi\u2019nin Yayin Organidir = J Turk Soc Algol"},{"key":"1310_CR105","doi-asserted-by":"publisher","first-page":"1202426","DOI":"10.3389\/fneur.2023.1202426","volume":"14","author":"CF Mullins","year":"2023","unstructured":"Mullins CF, Fuccaro M, Pang D, Min L, Andreou AP, Lambru G. A single infusion of intravenous lidocaine for primary headaches and trigeminal neuralgia: a retrospective analysis (in eng). Front Neurol. 2023;14:1202426. https:\/\/doi.org\/10.3389\/fneur.2023.1202426.","journal-title":"Front Neurol"},{"issue":"5","key":"1310_CR106","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1177\/10600280221120457","volume":"57","author":"B Yu","year":"2023","unstructured":"Yu B, Zhang W, Zhao C, Xing Y, Meng L, Luo F. Effectiveness, safety, and predictors of response to 5% lidocaine-medicated plaster for the treatment of patients with trigeminal neuralgia: a retrospective study (in eng). Ann Pharmacotherapy. 2023;57(5):527\u201334. https:\/\/doi.org\/10.1177\/10600280221120457.","journal-title":"Ann Pharmacotherapy"},{"issue":"5","key":"1310_CR107","doi-asserted-by":"publisher","first-page":"333102423116808","DOI":"10.1177\/03331024231168086","volume":"43","author":"X Zhou","year":"2023","unstructured":"Zhou X, Shen Y, Zhao C, Luo F. Lidocaine aerosol sprayed on oral and\/or nasal mucosa for the rescue of acute trigeminal neuralgia exacerbations: a retrospective study (in eng). Cephalalgia Int J Headache. 2023;43(5):3331024231168086. https:\/\/doi.org\/10.1177\/03331024231168086.","journal-title":"Cephalalgia Int J Headache"},{"issue":"1","key":"1310_CR108","doi-asserted-by":"publisher","first-page":"47","DOI":"10.17245\/jdapm.2024.24.1.47","volume":"24","author":"H Kim","year":"2024","unstructured":"Kim H, Kim HJ, Jung Y-H, Do W, Kim E-J. The effect of perineural injection therapy on neuropathic pain: a retrospective study (in eng). J Dent Anesth Pain Med. 2024;24(1):47\u201356. https:\/\/doi.org\/10.17245\/jdapm.2024.24.1.47.","journal-title":"J Dent Anesth Pain Med"},{"issue":"10","key":"1310_CR109","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1111\/head.14814","volume":"64","author":"C Zhao","year":"2024","unstructured":"Zhao C, et al. The PATCH trial: 5% lidocaine-medicated plaster for trigeminal neuralgia\u2014results of a multicentric, enriched enrollment, randomized withdrawal, double-blind, vehicle-controlled, parallel-group study (in eng). Headache. 2024;64(10):1318\u201328. https:\/\/doi.org\/10.1111\/head.14814.","journal-title":"Headache"},{"issue":"1","key":"1310_CR110","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s00701-025-06672-8","volume":"167","author":"MW Mohamed","year":"2025","unstructured":"Mohamed MW, Irem-Oko F, Sheikh A, Phillips N, McKinlay J, Anderson I. Lidocaine infusion for the treatment of intractable trigeminal neuralgia: retrospective case series and systematic review (in eng). Acta Neurochir. 2025;167(1):259. https:\/\/doi.org\/10.1007\/s00701-025-06672-8.","journal-title":"Acta Neurochir"},{"key":"1310_CR111","doi-asserted-by":"publisher","first-page":"7365148","DOI":"10.1155\/2018\/7365148","volume":"2018","author":"J Liu","year":"2018","unstructured":"Liu J, Xu YY, Zhang QL, Luo WF. Efficacy and safety of botulinum toxin type A in treating patients of advanced age with idiopathic trigeminal neuralgia (in eng). Pain Res Manag. 2018;2018:7365148. https:\/\/doi.org\/10.1155\/2018\/7365148.","journal-title":"Pain Res Manag"},{"issue":"8","key":"1310_CR112","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1111\/head.13608","volume":"59","author":"J Crespi","year":"2019","unstructured":"Crespi J, Bratbak D, Dodick DW, Matharu M, Jamt\u00f8y KA, Tronvik E. Pilot study of injection of onabotulinumtoxina toward the sphenopalatine ganglion for the treatment of classical trigeminal neuralgia (in eng). Headache. 2019;59(8):1229\u201339. https:\/\/doi.org\/10.1111\/head.13608.","journal-title":"Headache"},{"key":"1310_CR113","doi-asserted-by":"publisher","DOI":"10.3390\/toxins13090605","author":"K Yoshida","year":"2021","unstructured":"Yoshida K. Effects of botulinum toxin type A on pain among trigeminal neuralgia, myofascial temporomandibular disorders, and oromandibular dystonia (in eng). Toxins (Basel). 2021. https:\/\/doi.org\/10.3390\/toxins13090605.","journal-title":"Toxins (Basel)"},{"key":"1310_CR114","doi-asserted-by":"publisher","DOI":"10.3390\/toxins15110654","author":"Y Tereshko","year":"2023","unstructured":"Tereshko Y, et al. The therapeutic effect of botulinum toxin type A on trigeminal neuralgia: are there any differences between type 1 versus type 2 trigeminal neuralgia? (in eng). Toxins (Basel). 2023. https:\/\/doi.org\/10.3390\/toxins15110654.","journal-title":"Toxins (Basel)"},{"issue":"1","key":"1310_CR115","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s10194-024-01926-9","volume":"25","author":"M Thepsoparn","year":"2024","unstructured":"Thepsoparn M, Anukoolwittaya P, Toeypromthong P, Thanaboriboon C. Efficacy and safety profile of Onabotulinum toxin-A injection at sphenopalatine ganglion in trigeminal neuralgia: a prospective observational study (in eng). J Headache Pain. 2024;25(1):210. https:\/\/doi.org\/10.1186\/s10194-024-01926-9.","journal-title":"J Headache Pain"}],"container-title":["CNS Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-026-01310-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40263-026-01310-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-026-01310-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T04:18:29Z","timestamp":1783657109000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40263-026-01310-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":115,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["1310"],"URL":"https:\/\/doi.org\/10.1007\/s40263-026-01310-y","relation":{},"ISSN":["1172-7047","1179-1934"],"issn-type":[{"value":"1172-7047","type":"print"},{"value":"1179-1934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,29]]},"assertion":[{"value":"2 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Juliana Geremias Chichorro, Victor Augusto Benedicto dos Santos and Gerald W. Zamponi declare that they have no conflicts of interest that might be relevant to the contents of this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent (participation and publication)"}},{"value":"Data sharing is not applicable to this article as no datasets were generated or analyzed during the current study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability statement"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"The authors contributed equally to the conception and writing of this review. All authors have read and approved the final version.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}